Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia

Relapse is the major cause of treatment failure in acute lymphoblastic leukemia (ALL), yet there is no established treatment for relapsed ALL. To improve the induction remission rate, we modified the dose of idarubicin in the original Children's Cancer Group (CCG)-1884 protocol, and retrospecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yoon, Jong Hyung, Park, Jeong Ah, Kim, Eun Kyung, Kang, Hyoung Jin, Shin, Hee Young, Ahn, Hyo Seop
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Medical Sciences 2009
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2672129/
https://ncbi.nlm.nih.gov/pubmed/19399271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2009.24.2.281
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados